Bosh sahifa102460 ā¢ KRX
add
Reyon Pharmaceutical Co Ltd
Yopilish kursi
11Ā 400,00Ā ā©
Kunlik diapazon
11Ā 480,00Ā ā© - 12Ā 350,00Ā ā©
Yillik diapazon
9Ā 830,00Ā ā© - 14Ā 430,00Ā ā©
Bozor kapitalizatsiyasi
221,74Ā mlrd KRW
OŹ»rtacha hajm
55,93Ā ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
MarketWatch
1 kun oldin
The S&P 500 is undergoing a historic shift that could reshape the stock market
0,69%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 37,58Ā mlrd | -1,86% |
Joriy xarajat | 17,31Ā mlrd | 2,18% |
Sof foyda | -3,86Ā mlrd | -723,65% |
Sof foyda marjasi | -10,28 | -734,57% |
Har bir ulushga tushum | ā | ā |
EBITDA | 535,77Ā mln | -78,19% |
Amaldagi soliq stavkasi | -21,40% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 8,56Ā mlrd | 33,32% |
Jami aktivlari | 473,11Ā mlrd | -4,40% |
Jami passivlari | 239,99Ā mlrd | -3,02% |
Umumiy kapital | 233,12Ā mlrd | ā |
Tarqatilgan aksiyalar | 18,34Ā mln | ā |
Narxi/balansdagi bahosi | 0,90 | ā |
Aktivlardan daromad | -3,90% | ā |
Kapitaldan daromad | -4,14% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -3,86Ā mlrd | -723,65% |
Operatsiyalardan naqd pul | -1,73Ā mlrd | -198,47% |
Sarmoyadan naqd pul | -1,45Ā mlrd | 74,45% |
Moliyadan naqd pul | 3,07Ā mlrd | 29,31% |
Naqd pulning sof oŹ»zgarishi | -100,81Ā mln | 93,12% |
BoŹ»sh pul | -5,87Ā mlrd | -108,59% |
Haqida
Tashkil etilgan
1955
Sayt
Xodimlar soni
448
